ZENI: Q2 2025 saw 10% revenue growth, positive profit, and key wins in Finland and the UK

About this update from Zenicor Medical Systems Ab

Revenue grew 10% year-over-year in Q2 2025, with positive operating profit and major contract wins in Finland and the UK. Cash flow improved, debt reduced, and new equity raised to support continued growth and international expansion.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Zenicor Medical Systems Ab